Article
Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation
4 Aug 2015
Abstract excerpt
BACKGROUND AND AIM: The long-term survival of patients with hepatocellular carcinoma remains unsatisfactory because of the presence of cancer stem cells (CSCs), which are responsible for tumor recurrence and chemoresistance after hepatectomy. Drugs that selectively target CSCs thus offer great promise for cancer treatment. Although the antitumor effects of epigallocatechin gallate (EGCG) have been reported in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
